mycolio DISINFECTANT & mycolio DISINFECTANT WIPES
mycolio DISINFECTANT & mycolio DISINFECTANT WIPES have a unique formulation of four active ingredients that work synergistically to create an unparalleled broad spectrum disinfectant ideal for daily use in dental offices. In addition to disinfecting against HIV-1, mycolio DISINFECTANT & mycolio DISINFECTANT WIPES are also effective against Hepatitis B (DHBV) and Hepatitis C (BVDV) to significantly reduce the of risk of cross-infection from these three commonly feared bloodborne viral pathogens. mycolio DISINFECTANT & mycolio DISINFECTANT WIPES may be used on a multitude of non porous hard surfaces and is also gentle enough to use on dental chairs!*
Wipes/Refill Pouches - EPA Reg. No. 88897-1-90841
Spray/Refill Jug - EPA Reg. No. 88897-2-90841
If referencing the EPA’s List N: Disinfectants for Use Against SARS-CoV-2 please note that mycolio is listed under the product name Panther.
maxill owns Panther Disinfectant Wipe EPA Reg. 88897-1 and Panther Disinfectant EPA Reg. 88897-2. These products are marketed in the USA under the Alternate Brand Name mycolio. maxill USA owns and distributes mycolio Disinfectant Wipe EPA Reg. 88897-1-90841 and mycolio Disinfectant EPA Reg. 88897-2-90841.
Inactivates SARS-CoV-2
mycolio Disinfectant Wipes have undergone independent laboratory testing and have demonstrated a 1-minute kill time against the SARS-CoV-2 Virus. Results are based on GLP testing and are pending regulatory approval.
Learn More
In stock
Related Products
†Recent Testing Reveals maxill’s mycolio Disinfectant Wipe is Effective against SARS-CoV-2*
maxill is pleased to announce that our mycolio Disinfectant Wipes have been tested using Good Laboratory Practices and proven effective to inactivate in 1 minute SARS-CoV-2, the virus that causes COVID-19.
maxill is a provider of infection control products and has been able to provide its customers with hard surface disinfectants during the period time that Emerging Viral Pathogen policies have been in place. Though these policies are temporarily enabled by the EPA, maxill realizes it is necessary to ensure for the long term that we can provide fully qualified products to disinfect against SARS-CoV-2. For the interim and within the scopes of these policies, our mycolio Disinfectant Wipes are expected to be effective against SARS-CoV-2. Now with this recent testing, and *subject to regulatory approval by the EPA, the labels for mycolio Disinfectant Wipes will be updated to include this new information.
